Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2007 by QDose Limited.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
QDose Limited
ClinicalTrials.gov Identifier:
NCT00426920
First received: January 24, 2007
Last updated: NA
Last verified: January 2007
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given